A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with far fewer side effects than other medications.
from Latest Science News -- ScienceDaily https://ift.tt/2P4cnh4
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment